Endogenous Cardiac Steroids in Bipolar Disorder: State of the Art
- PMID: 35163766
- PMCID: PMC8836531
- DOI: 10.3390/ijms23031846
Endogenous Cardiac Steroids in Bipolar Disorder: State of the Art
Abstract
Bipolar disorder (BD) is a severe psychiatric illness with a poor prognosis and problematic, suboptimal, treatments. Treatments, borne of an understanding of the pathoetiologic mechanisms, need to be developed in order to improve outcomes. Dysregulation of cationic homeostasis is the most reproducible aspect of BD pathophysiology. Correction of ionic balance is the universal mechanism of action of all mood stabilizing medications. Endogenous sodium pump modulators (collectively known as endogenous cardiac steroids, ECS) are steroids which are synthesized in and released from the adrenal gland and brain. These compounds, by activating or inhibiting Na+, K+-ATPase activity and activating intracellular signaling cascades, have numerous effects on cell survival, vascular tone homeostasis, inflammation, and neuronal activity. For the past twenty years we have addressed the hypothesis that the Na+, K+-ATPase-ECS system may be involved in the etiology of BD. This is a focused review that presents a comprehensive model pertaining to the role of ECS in the etiology of BD. We propose that alterations in ECS metabolism in the brain cause numerous biochemical changes that underlie brain dysfunction and mood symptoms. This is based on both animal models and translational human results. There are data that demonstrate that excess ECS induce abnormal mood and activity in animals, while a specific removal of ECS with antibodies normalizes mood. There are also data indicating that circulating levels of ECS are lower in manic individuals, and that patients with BD are unable to upregulate synthesis of ECS under conditions that increase their elaboration in non-psychiatric controls. There is strong evidence for the involvement of ion dysregulation and ECS function in bipolar illness. Additional research is required to fully characterize these abnormalities and define future clinical directions.
Keywords: Na+, K+-ATPase; bipolar disorder; endogenous cardiac steroids; endogenous ouabain; ouabain.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Involvement of the Na+, K+-ATPase α1 Isoform and Endogenous Cardiac Steroids in Depression- and Manic-like Behaviors.Int J Mol Sci. 2024 Jan 29;25(3):1644. doi: 10.3390/ijms25031644. Int J Mol Sci. 2024. PMID: 38338921 Free PMC article.
-
Na⁺, K⁺-ATPase Signaling and Bipolar Disorder.Int J Mol Sci. 2018 Aug 7;19(8):2314. doi: 10.3390/ijms19082314. Int J Mol Sci. 2018. PMID: 30087257 Free PMC article. Review.
-
Role of endogenous ouabain in the etiology of bipolar disorder.Int J Bipolar Disord. 2021 Feb 1;9(1):6. doi: 10.1186/s40345-020-00213-1. Int J Bipolar Disord. 2021. PMID: 33523310 Free PMC article. Review.
-
Onset of bipolar disorder by COVID-19: The roles of endogenous ouabain and the Na,K-ATPase.J Psychiatr Res. 2024 Nov;179:60-68. doi: 10.1016/j.jpsychires.2024.08.035. Epub 2024 Aug 31. J Psychiatr Res. 2024. PMID: 39260109 Review.
-
Na+, K+-ATPase α Isoforms and Endogenous Cardiac Steroids in Prefrontal Cortex of Bipolar Patients and Controls.Int J Mol Sci. 2020 Aug 17;21(16):5912. doi: 10.3390/ijms21165912. Int J Mol Sci. 2020. PMID: 32824628 Free PMC article.
Cited by
-
Vanadium in Bipolar Disorders-Reviving an Old Hypothesis.Int J Mol Sci. 2022 Nov 11;23(22):13901. doi: 10.3390/ijms232213901. Int J Mol Sci. 2022. PMID: 36430373 Free PMC article.
-
Involvement of the Na+, K+-ATPase α1 Isoform and Endogenous Cardiac Steroids in Depression- and Manic-like Behaviors.Int J Mol Sci. 2024 Jan 29;25(3):1644. doi: 10.3390/ijms25031644. Int J Mol Sci. 2024. PMID: 38338921 Free PMC article.
-
Sensational site: the sodium pump ouabain-binding site and its ligands.Am J Physiol Cell Physiol. 2024 Apr 1;326(4):C1120-C1177. doi: 10.1152/ajpcell.00273.2023. Epub 2024 Jan 15. Am J Physiol Cell Physiol. 2024. PMID: 38223926 Free PMC article. Review.
-
Differentially Altered Metabolic Pathways in the Amygdala of Subjects with Schizophrenia, Bipolar Disorder and Major Depressive Disorder.medRxiv [Preprint]. 2024 Apr 19:2024.04.17.24305854. doi: 10.1101/2024.04.17.24305854. medRxiv. 2024. Update in: Schizophr Bull. 2024 Nov 11:sbae193. doi: 10.1093/schbul/sbae193. PMID: 38699334 Free PMC article. Updated. Preprint.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous